主动脉血管支架市场规模、份额及成长分析（按产品、最终用户和地区）－2025 年至 2032 年产业预测

Aortic Stent Grafts Market Size, Share, and Growth Analysis, By Product (Abdominal Aortic Stent Graft, Thoracic Aortic Stent Graft), By End User (Hospitals, Ambulatory Surgical Centers), By Region - Industry Forecast 2025-2032

出版日期: 2025年03月06日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2023 年全球主动脉血管支架市场规模价值 32 亿美元，预计将从 2024 年的 33.5 亿美元成长到 2032 年的 48.4 亿美元，预测期内（2025-2032 年）的复合年增长率为 4.7%。

全球主动脉血管支架市场预计将显着成长，这主要是由于心血管疾病的增加和预期寿命的增加导致主动脉瘤盛行率不断上升。随着患者和医疗保健提供者越来越倾向于血管内修復而非传统手术，对恢復更快、不适感更少的微创手术的需求正在急剧上升。这是由于都市化、医疗保健基础设施的进步以及旨在改进支架设计的持续研究和开发等因素造成的。然而，它面临的挑战包括对新的血管内动脉瘤修復（EVAR）治疗的认识低、内漏等併发症的风险以及服务不足地区熟练医务人员的短缺。解决这些障碍是充分发挥市场潜力的关键。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业市场定位（2024年）
主要市场参与者所采取的策略
近期市场趋势
公司市场占有率分析（2024年）
主要企业简介
- 公司详情
- 产品系列分析
- 公司分部份额分析
- 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

Medtronic（Ireland）
WL Gore & Associates, Inc.（USA）
Cook Medical（USA）
Terumo Aortic（Japan）
Endologix LLC（USA）
Jotec（Germany）
MicroPort Scientific Corporation（China）
Corcym（Italy）
Edwards Lifesciences Corporation（USA）
Bentley Healthcare Pvt. Ltd.（India）
Braile Biomedica（Brazil）
Cardinal Health（USA）
InSitu Technologies Inc.（USA）
Artivion Inc.（USA）
Cryolife Inc.（USA）
Lombard Medical Inc.（UK）
Bolton Medical（Spain）

结论和建议

简介目录

Product Code: SQMIG35B2078

Global Aortic Stent Grafts Market size was valued at USD 3.2 billion in 2023 and is poised to grow from USD 3.35 billion in 2024 to USD 4.84 billion by 2032, growing at a CAGR of 4.7% during the forecast period (2025-2032).

The global aortic stent graft market is poised for notable growth, primarily driven by an increasing prevalence of aortic aneurysms linked to rising cardiovascular diseases and longer life expectancies. As patients and healthcare providers favor endovascular repairs over traditional surgeries, there is a surge in demand for minimally invasive procedures that offer quicker recovery times and reduced discomfort. Contributing factors include urbanization, advancements in healthcare infrastructure, and ongoing research and development targeting improved stent designs. However, market growth faces challenges such as limited awareness of new endovascular aneurysm repair (EVAR) treatments, risks of complications like endoleaks, and a shortage of skilled medical professionals in underserved regions. Addressing these hurdles will be critical for maximizing the market's potential.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Aortic Stent Grafts market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Aortic Stent Grafts Market Segments Analysis

Global Aortic Stent Grafts Market is segmented by Product, End User and region. Based on Product, the market is segmented into Abdominal Aortic Stent Graft and Thoracic Aortic Stent Graft. Based on End User, the market is segmented into Hospitals and Ambulatory Surgical Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Aortic Stent Grafts Market

The global aortic stent grafts market is expected to experience significant growth throughout the forecast period, driven by several key factors. The preference for endovascular repair techniques over traditional open surgical methods is gaining momentum, alongside rising life expectancy rates. Additionally, the increasing adoption of minimally invasive surgical procedures contributes to this trend. The surge in clinical trials and FDA approvals aimed at developing innovative aortic stent graft designs further propels market expansion. As these elements align, they collectively enhance the demand for aortic stent grafts, positioning the market for promising advancements and opportunities in the years ahead.

Restraints in the Global Aortic Stent Grafts Market

However, the growth of the Global Aortic Stent Grafts market may be hindered by several factors, including a shortage of properly trained healthcare professionals and insufficient knowledge regarding the new Endovascular Aneurysm Repair (EVAR) techniques. Additionally, concerns about potential complications, such as endoleaks and other risks associated with aortic stent grafts, could further limit market development during the forecast period. These challenges may impact the adoption and implementation of advanced treatments in various healthcare settings, ultimately affecting the overall market dynamics for aortic stent grafts.

Market Trends of the Global Aortic Stent Grafts Market

The Global Aortic Stent Grafts market is poised for significant growth from 2023 to 2030, driven by an ageing demographic and a rising incidence of aortic aneurysms. As the prevalence of cardiovascular diseases increases, coupled with heightened awareness regarding stenting and grafting technologies, demand for these medical devices is expected to burgeon. Additionally, the landscape is being positively influenced by a surge in regulatory approvals and rapid advancements in medical technology, which enhance the efficacy and safety of stent grafts. Collectively, these factors are shaping a robust market trend, positioning aortic stent grafts as critical components in cardiovascular healthcare solutions.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Aortic Stent Grafts Market Size by Product & CAGR (2025-2032)

Market Overview
Abdominal Aortic Stent Graft
Thoracic Aortic Stent Graft

Global Aortic Stent Grafts Market Size by End User & CAGR (2025-2032)

Market Overview
Hospitals
Ambulatory Surgical Centers

Global Aortic Stent Grafts Market Size & CAGR (2025-2032)

North America (Product, End User)
- US
- Canada
Europe (Product, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Medtronic (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
W. L. Gore & Associates, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cook Medical (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Aortic (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Endologix LLC (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jotec (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroPort Scientific Corporation (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Corcym (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Edwards Lifesciences Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bentley Healthcare Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Braile Biomedica (Brazil)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardinal Health (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
InSitu Technologies Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Artivion Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cryolife Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lombard Medical Inc. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bolton Medical (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments